(1S,2S)-1-(4-hydroxyphenyl)-2-(4- hydroxy-4-phenylipiperidin-1-yl)-1-propanolmethanesulfonate trihydrate
US6008233A · kind A · utility
16Cited by
2References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 7, 1998 |
| Grant date | Dec 28, 1999 |
| Priority date | — |
| Expiry date | May 7, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the trihydrate of the mesylate salt of (1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propano l, pharmaceutical compositions containing said compound and methods of treating disorders of the central nervous system by administering said compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.